| Shelby N Kenison, ATC | |
|
28675 740th Ave, Clarks Grove, MN 56016-4041 | |
| (507) 213-3487 | |
| Not Available |
| Full Name | Shelby N Kenison |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 28675 740th Ave, Clarks Grove, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790020949 | NPI | - | NPPES |
| 1790020949 | Other | MN | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 2306 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shelby N Kenison, ATC 28675 740th Ave, Clarks Grove, MN 56016-4041 Ph: (507) 213-3487 | Shelby N Kenison, ATC 28675 740th Ave, Clarks Grove, MN 56016-4041 Ph: (507) 213-3487 |
News Archive
GATC Biotech's new sequencing laboratory will be their second in Germany and will be located in the Life Science Center Düsseldorf. Through the new facilities, scientists from Northern Germany and adjacent countries will benefit from GATC Biotech's special overnight service, called NightXpress, which was first introduced in 2007.
Of the 4 million babies born in the United States each year around 11% have been exposed to alcohol or illicit drugs in the womb.
As the debate over health care reform continues to unfold in town hall meetings and on Capitol Hill, a new study by two Harvard researchers has found that taxing job-based health benefits would heavily penalize insured, working families.
A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative.
› Verified 2 days ago